{"disease":{"id":"angina-pectoris","name":"Angina pectoris","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":29,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"atorvastatin","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lipitor","generic_name":"atorvastatin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"HMG-CoA reductase","drug_class":"HMG-CoA reductase inhibitor (statin)","quality_score":77,"revenue":"1000.0","mechanism":"Selective competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis."},{"drug_id":"methylchromone","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Crodimyl","generic_name":"METHYLCHROMONE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":"Crodimyl works by modulating the activity of a specific cellular pathway to improve blood flow to the heart."},{"drug_id":"molsidomine","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Motazomin","generic_name":"MOLSIDOMINE","company_name":"","drug_phase":"phase_2","molecular_target":"Estrogen receptor","drug_class":"molsidomine","quality_score":41,"revenue":null,"mechanism":"Molsidomine works by releasing nitric oxide, which relaxes blood vessels and improves blood flow to the heart."},{"drug_id":"trimetazidine","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vastarel","generic_name":"TRIMETAZIDINE","company_name":"","drug_phase":"discontinued","molecular_target":"","drug_class":"trimetazidine","quality_score":null,"revenue":null,"mechanism":"Trimetazidine works by optimizing the heart's energy production, reducing the amount of oxygen required by the heart muscle."},{"drug_id":"ranolazine","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ranexa","generic_name":"RANOLAZINE","company_name":"Menarini Intl","drug_phase":"marketed","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"Anti-anginal [EPC]","quality_score":75,"revenue":null,"mechanism":"Ranexa works by blocking the sodium channels in heart muscle cells to reduce the amount of calcium that enters the cells during heart contractions."},{"drug_id":"bivalirudin","indication_name":"Unstable Angina Pectoris during PTCA","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Angiomax","generic_name":"BIVALIRUDIN","company_name":"Novartis","drug_phase":"marketed","molecular_target":"thrombin","drug_class":"Anti-coagulant [EPC]","quality_score":10,"revenue":null,"mechanism":"Bivalirudin directly inhibits thrombin by binding to its catalytic site and anion-binding exosite, preventing thrombus formation."},{"drug_id":"glyceryl-trinitrate","indication_name":"Angina Pectoris Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nitroglycerin","generic_name":"glyceryl trinitrate","company_name":"Fougera","drug_phase":"marketed","molecular_target":"guanylate cyclase","drug_class":"Nitrate Vasodilator [EPC]","quality_score":65,"revenue":null,"mechanism":"Nitroglycerin forms nitric oxide, activating guanylate cyclase and increasing cyclic GMP, leading to smooth muscle relaxation and vasodilation."},{"drug_id":"glyceryl-trinitrate","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nitroglycerin","generic_name":"glyceryl trinitrate","company_name":"Fougera","drug_phase":"marketed","molecular_target":"guanylate cyclase","drug_class":"Nitrate Vasodilator [EPC]","quality_score":65,"revenue":null,"mechanism":"Nitroglycerin forms nitric oxide, activating guanylate cyclase and increasing cyclic GMP, leading to smooth muscle relaxation and vasodilation."},{"drug_id":"ivabradine","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Corlanor","generic_name":"IVABRADINE","company_name":"Amgen","drug_phase":"marketed","molecular_target":"Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1","drug_class":"Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker","quality_score":43,"revenue":null,"mechanism":""},{"drug_id":"non-interventional-study","indication_name":"Angina Pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non-Interventional Study","generic_name":"non-interventional-study","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Vitamin K epoxide reductase","drug_class":"Anticoagulant","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"nifedipine","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Procardia","generic_name":"NIFEDIPINE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Voltage-dependent L-type calcium channel subunit alpha-1C","drug_class":"Dihydropyridine Calcium Channel Blocker [EPC]","quality_score":53,"revenue":null,"mechanism":""},{"drug_id":"verapamil","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Isoptin","generic_name":"VERAPAMIL","company_name":"","drug_phase":"marketed","molecular_target":"Voltage-dependent L-type calcium channel subunit alpha-1C","drug_class":"Calcium Channel Blocker","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"metoprolol","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lopressor","generic_name":"metoprolol","company_name":"Generic (originally Ciba-Geigy/Novartis)","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, 5-hydroxytryptamine receptor 1A","drug_class":"Beta-1 selective blocker","quality_score":58,"revenue":null,"mechanism":"Cardioselective beta-1 adrenergic receptor blocker that reduces heart rate, blood pressure, and myocardial oxygen demand."},{"drug_id":"nitroglycerin","indication_name":"Acute relief of angina pectoris due to coronary artery disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"NITROGLYCERIN","company_name":"","drug_phase":"marketed","molecular_target":"Nitric oxide synthase pathway","drug_class":"Nitrate Vasodilator [EPC]","quality_score":10,"revenue":null,"mechanism":"Nitroglycerin forms nitric oxide, which activates guanylate cyclase, leading to increased cyclic GMP and subsequent vasodilation in smooth muscle."},{"drug_id":"mibefradil","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Posicor","generic_name":"MIBEFRADIL","company_name":"","drug_phase":"marketed","molecular_target":"Voltage-dependent T-type calcium channel subunit alpha-1I","drug_class":"mibefradil","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"tilisolol","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Selecal","generic_name":"TILISOLOL","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"tilisolol","quality_score":null,"revenue":null,"mechanism":"Selecal works by blocking beta-1 adrenergic receptors in the heart, reducing heart rate and blood pressure."},{"drug_id":"tenitramine","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"tenitramine","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"Vasodilators Organic Nitrates","quality_score":null,"revenue":null,"mechanism":"Tenitramine works by releasing nitric oxide, which relaxes blood vessels and improves blood flow to the heart."},{"drug_id":"clonitrate","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dinitrochlorhydrin","generic_name":"CLONITRATE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Clonitrate works by relaxing blood vessels to improve blood flow to the heart."},{"drug_id":"celiprolol","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Selectol","generic_name":"CELIPROLOL","company_name":"","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor","drug_class":"celiprolol","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"diltiazem","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cardizem","generic_name":"diltiazem","company_name":"Generic (originally Tanabe Seiyaku)","drug_phase":"marketed","molecular_target":"Voltage-dependent calcium channel gamma-1 subunit, Multidrug resistance protein 1, Solute carrier family 22 member 1","drug_class":"Calcium channel blocker (non-dihydropyridine, benzothiazepine)","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"propranolol","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Inderal","generic_name":"propranolol","company_name":"Generic (originally ICI/AstraZeneca)","drug_phase":"marketed","molecular_target":"Nuclear receptor subfamily 2 group E member 1, 5-hydroxytryptamine receptor 6, Cytochrome P450 1A2","drug_class":"Non-selective beta-blocker","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"procardia-xl","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Procardia","generic_name":"Nifedipine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Voltage-dependent L-type calcium channel subunit alpha-1C","drug_class":"Dihydropyridine Calcium Channel Blocker [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"nadolol","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Corgard","generic_name":"NADOLOL","company_name":"Uswm","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta-Adrenergic Blocker [EPC]","quality_score":54,"revenue":null,"mechanism":""},{"drug_id":"isosorbide-mononitrate","indication_name":"Angina Pectoris Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Monoket","generic_name":"ISOSORBIDE MONONITRATE","company_name":"","drug_phase":"marketed","molecular_target":"Atrial natriuretic peptide receptor 1","drug_class":"Nitrate Vasodilator [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"isosorbide-mononitrate","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Monoket","generic_name":"ISOSORBIDE MONONITRATE","company_name":"","drug_phase":"marketed","molecular_target":"Atrial natriuretic peptide receptor 1","drug_class":"Nitrate Vasodilator [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"lipitor","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lipitor","generic_name":"Atorvastatin Calcium","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"3-hydroxy-3-methylglutaryl-coenzyme A reductase","drug_class":"atorvastatin","quality_score":10,"revenue":null,"mechanism":"Lipitor is a selective, competitive inhibitor of HMG-CoA reductase, a key enzyme in cholesterol synthesis."},{"drug_id":"bepridil","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Org 5730","generic_name":"BEPRIDIL","company_name":"","drug_phase":"marketed","molecular_target":"Voltage-dependent P/Q-type calcium channel subunit alpha-1A","drug_class":"High Risk QT Prolonging Agents","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"nicardipine","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cardene","generic_name":"NICARDIPINE","company_name":"Hikma Intl Pharms","drug_phase":"marketed","molecular_target":"Voltage-dependent T-type calcium channel subunit alpha-1H","drug_class":"Dihydropyridine Calcium Channel Blocker","quality_score":80,"revenue":null,"mechanism":"Cardene works by blocking calcium channels in the heart and blood vessels, which helps to relax and widen blood vessels, reducing blood pressure and heart workload."},{"drug_id":"atenolol","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tenoretic 100","generic_name":"ATENOLOL","company_name":"Twi Pharms","drug_phase":"marketed","molecular_target":"Adenosine receptor A3","drug_class":"beta-Adrenergic Blocker [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"amlodipine","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norvasc","generic_name":"amlodipine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Voltage-dependent calcium channel gamma-1 subunit, 5-hydroxytryptamine receptor 6","drug_class":"Calcium channel blocker (dihydropyridine)","quality_score":55,"revenue":null,"mechanism":"Long-acting dihydropyridine calcium channel blocker that relaxes vascular smooth muscle, reducing blood pressure and myocardial oxygen demand."},{"drug_id":"nitroglycerine","indication_name":"Angina Pectoris Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"nitroglycerine","company_name":"University Hospital, Ghent","drug_phase":"marketed","molecular_target":"Atrial natriuretic peptide receptor 1, Soluble guanylate cyclase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"nitroglycerine","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"nitroglycerine","company_name":"University Hospital, Ghent","drug_phase":"marketed","molecular_target":"Atrial natriuretic peptide receptor 1, Soluble guanylate cyclase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"ranexa","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ranexa","company_name":"Midwest Cardiovascular Research Foundation","drug_phase":"marketed","molecular_target":"Multidrug resistance protein 1, Potassium voltage-gated channel subfamily H member 2, Sodium channel protein type 5 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"metoprolol","indication_name":"Angina Pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lopressor","generic_name":"metoprolol","company_name":"Generic (originally Ciba-Geigy/Novartis)","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, 5-hydroxytryptamine receptor 1A","drug_class":"Beta-1 selective blocker","quality_score":58,"revenue":null,"mechanism":"Cardioselective beta-1 adrenergic receptor blocker that reduces heart rate, blood pressure, and myocardial oxygen demand."},{"drug_id":"amlodipin","indication_name":"Angina pectoris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Amlodipin","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Voltage-dependent calcium channel gamma-1 subunit, 5-hydroxytryptamine receptor 6","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":35,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04008173","title":"The International Survey of Acute Coronary Syndromes-ARCHIVES","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":130000,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT07063147","title":"TTE Improves Clinical Management of Stable Chest Pain","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Tianjin Chest Hospital","has_results":false},{"nct_id":"NCT01218776","title":"International Survey of Acute Coronary Syndromes","phase":"","overall_status":"RECRUITING","enrollment_count":36000,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT06614023","title":"Impact of Body Weight on Outcomes of Patients Undergoing Coronary Artery Bypass Grafting","phase":"","overall_status":"COMPLETED","enrollment_count":6448,"lead_sponsor_name":"Medical University of Silesia","has_results":false},{"nct_id":"NCT06075602","title":"COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Luzerner Kantonsspital","has_results":false},{"nct_id":"NCT01674803","title":"Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT)","phase":"NA","overall_status":"COMPLETED","enrollment_count":3514,"lead_sponsor_name":"Foundation of Cardiovascular Research and Education Enschede","has_results":false},{"nct_id":"NCT03216733","title":"SORT OUT X - Combo Stent Versus ORSIRO Stent","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3148,"lead_sponsor_name":"Aarhus University Hospital Skejby","has_results":false},{"nct_id":"NCT06384846","title":"AI Algorithms in Prediction of ACS Based on Leukocyte Properties","phase":"","overall_status":"RECRUITING","enrollment_count":2700,"lead_sponsor_name":"RobotDreams GmbH","has_results":false},{"nct_id":"NCT05380063","title":"Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2300,"lead_sponsor_name":"China National Center for Cardiovascular Diseases","has_results":false},{"nct_id":"NCT06101862","title":"Coronary Computed Tomography Versus Invasive Angiography for Non-ST Elevation Acute Coronary Syndrome","phase":"NA","overall_status":"RECRUITING","enrollment_count":2300,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT03620760","title":"Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":2036,"lead_sponsor_name":"Xiaofan Wu","has_results":false},{"nct_id":"NCT04988685","title":"SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Luzerner Kantonsspital","has_results":false},{"nct_id":"NCT06708000","title":"Personalized Evaluation of Susptected Myocardial Ischemia","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2000,"lead_sponsor_name":"Gødstrup Hospital","has_results":false},{"nct_id":"NCT05482009","title":"Treatment of Angina Pectoris After Coronary Revascularization With Integrated Traditional Chinese and Western Medicine","phase":"","overall_status":"COMPLETED","enrollment_count":2000,"lead_sponsor_name":"Jiangsu Famous Medical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT03392415","title":"The NOrdic-Baltic Randomized Registry Study for Evaluation of PCI in Chronic Total Coronary Occlusion","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Leif Thuesen","has_results":false},{"nct_id":"NCT06545448","title":"Appropriateness of Angioplasty in Patients With Chronic Coronary Syndromes","phase":"","overall_status":"RECRUITING","enrollment_count":1875,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT04475380","title":"Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents","phase":"","overall_status":"COMPLETED","enrollment_count":1757,"lead_sponsor_name":"Foundation of Cardiovascular Research and Education Enschede","has_results":false},{"nct_id":"NCT03481712","title":"Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease 2","phase":"","overall_status":"COMPLETED","enrollment_count":1732,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT05050773","title":"Registry Study of Medical Therapy in Patients With Angina Pectoris(GREAT)","phase":"","overall_status":"COMPLETED","enrollment_count":1556,"lead_sponsor_name":"Beijing Anzhen Hospital","has_results":false},{"nct_id":"NCT04707859","title":"Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease 3","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT06808321","title":"Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":800,"lead_sponsor_name":"The Society of Prevention and Awareness of Cardiovascular Diseases","has_results":false},{"nct_id":"NCT02094963","title":"Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Seung-Jung Park","has_results":false},{"nct_id":"NCT04175626","title":"Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions","phase":"","overall_status":"COMPLETED","enrollment_count":556,"lead_sponsor_name":"Biotronik, Inc.","has_results":true},{"nct_id":"NCT06945094","title":"A Multi-center, Real-World Clinical Trial of caIMR on Two Specific Kinds of Patients.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":508,"lead_sponsor_name":"Ge Junbo","has_results":false},{"nct_id":"NCT07112547","title":"Occurrence of Severe Cardiac Rhythm and Conduction Disturbances in Emergency Department Patients With Non-ST Elevation Acute Coronary Syndrome","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT07449052","title":"Comprehensive Invasive Physiological Evaluation of Obstructive Coronary Artery Disease","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":450,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT03700567","title":"Safety and Efficacy of Low Temperature Contrast in UAP Patients During PCI (LOTA-I)","phase":"NA","overall_status":"COMPLETED","enrollment_count":440,"lead_sponsor_name":"Nanjing First Hospital, Nanjing Medical University","has_results":false},{"nct_id":"NCT03794713","title":"A Randomized, Two-arm, Open Label Study to evalUate the Effect of a Smart Phone-based Patient Support Tool On Patient AdheRence of Treatment in Stable Angina Patients Prescribed Beta-blockers in China (SUPPORT)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":432,"lead_sponsor_name":"Shenyang Northern Hospital","has_results":false},{"nct_id":"NCT02901353","title":"A Prospective, Single-arm, Multi-centre, Observational, Real World Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Meril Life Sciences Pvt. Ltd.","has_results":false},{"nct_id":"NCT05493904","title":"PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment of COMPLEX Lesion (PRECISION-COMPLEX)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":320,"lead_sponsor_name":"Chonnam National University Hospital","has_results":false},{"nct_id":"NCT03646760","title":"The Improving ATTENDance to Cardiac Rehabilitation Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":282,"lead_sponsor_name":"Henry Ford Health System","has_results":true},{"nct_id":"NCT04805814","title":"Coronary Microvascular Angina Cardiac Magnetic Resonance Imaging (CorCMR) Trial","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":280,"lead_sponsor_name":"NHS National Waiting Times Centre Board","has_results":false},{"nct_id":"NCT04984954","title":"Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":264,"lead_sponsor_name":"Shanghai Hutchison Pharmaceuticals Limited","has_results":false},{"nct_id":"NCT03477890","title":"Coronary Microvascular Function and CT Coronary Angiography (CorCTCA)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":250,"lead_sponsor_name":"NHS National Waiting Times Centre Board","has_results":false},{"nct_id":"NCT04897126","title":"Efficacy and Safety of Shexiang Baoxin Pill in Patients With Ischemia With Non-Obstructive Coronary Artery","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Shanghai Hutchison Pharmaceuticals Limited","has_results":false},{"nct_id":"NCT04938661","title":"Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE)","phase":"NA","overall_status":"COMPLETED","enrollment_count":206,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT04325867","title":"Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Professor Adrian Covic","has_results":false},{"nct_id":"NCT04853511","title":"Comprehensive Assessment of Interconnection Between Brain Emotional Activity and Coronary Plaque Instability","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Korea University Guro Hospital","has_results":false},{"nct_id":"NCT02773615","title":"CT Perfusion Added to CT Angiography","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT03028025","title":"Comparing TR Band to Statseal in Conjunction With TR Band","phase":"NA","overall_status":"COMPLETED","enrollment_count":184,"lead_sponsor_name":"VA Long Beach Healthcare System","has_results":true},{"nct_id":"NCT03341663","title":"The Diagnostic Value of Acupoint Sensitization Based on Stable Angina Pectoris","phase":"","overall_status":"COMPLETED","enrollment_count":183,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT05563701","title":"Evaluation of the LVivo Image Quality Scoring (IQS)","phase":"","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"DiA Imaging Analysis Ltd","has_results":false},{"nct_id":"NCT06480097","title":"Bidirectional Cohort Study on Improvement of Quality of Life in Patients After Coronary Intervention With Kuanxiong Aerosol","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT03409731","title":"Absorb GT1 Japan PMS","phase":"NA","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"Abbott Medical Devices","has_results":true},{"nct_id":"NCT06606821","title":"The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":124,"lead_sponsor_name":"Tina Vilsbøll","has_results":false},{"nct_id":"NCT05711849","title":"Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":110,"lead_sponsor_name":"Barts & The London NHS Trust","has_results":false},{"nct_id":"NCT05374694","title":"Angina, Physiology, Biology (ANgina, FIsiologia BIOlogia)","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Hospital Arnau de Vilanova","has_results":false},{"nct_id":"NCT02747329","title":"A Comparative Evaluation of the Extent of Neointima Formation at 1 Month and 2 Months After Implantation Using OCT","phase":"NA","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"Sino Medical Sciences Technology Inc.","has_results":false},{"nct_id":"NCT06181799","title":"Volatilome and Single-Lead Electrocardiogram Optimize Ischemic Heart Disease Diagnosis Using Machine Learning Models","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"I.M. Sechenov First Moscow State Medical University","has_results":true},{"nct_id":"NCT00093223","title":"A Safety Study of ABI-007 for In-Stent Restenosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"Celgene","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}